IPO registrations (S-1, F-1) · Registrants
SENOMYX INC
- SEC CIK
- 1123979 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2001-02-21, last 2004-06-18; 2 initial registrations, 6 amendments
- Outcome
- Final prospectus filed 2004-06-22; withdrawal requested 2001-09-05
- Industry (SIC)
- Services-Commercial Physical & Biological Research 8731
- Incorporated in
- DE
- Business address
- 4767 NEXUS CENTRE DRIVE, San Diego, CA 92121
- EIN
- 33-0843840
- EDGAR entity type
- operating
- Insiders and CEO pay
- SENOMYX INC on the corporate pages
Offering terms
- Proposed price range
- $6.00–$7.00 per share (S-1/A filed 2004-06-18)
- Final price
- $6.00 per share, within the range (424B4 filed 2004-06-22, an initial public offering)
- Shares sold
- 6,000,000
- Gross proceeds
- $36,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol SNMX
- Lead underwriters
- Citigroup
- Syndicate
- Deutsche Bank; Needham & Company; First Albany Capital
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form 5500 plan sponsor: SENOMYX, INC. EXACT (EIN (EXACT))
- SEC filer: SENOMYX INC EXACT (CIK (EXACT))
- Person page: Christopher J Twomey Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: Dennis F O'Brien Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 10
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2001-02-21 | S-1 | S-1 (registration) | SENOMYX INC | 0000912057-01-006387 ↗ |
| 2001-09-05 | RW | RW (withdrawal request) | SENOMYX INC | 0000912057-01-531395 ↗ |
| 2004-03-29 | S-1 | S-1 (registration) | SENOMYX INC | 0001047469-04-009735 ↗ |
| 2004-04-14 | S-1/A | S-1/A (amendment) | SENOMYX INC | 0001047469-04-012007 ↗ |
| 2004-05-05 | S-1/A | S-1/A (amendment) | SENOMYX INC | 0001047469-04-016019 ↗ |
| 2004-05-24 | S-1/A | S-1/A (amendment) | SENOMYX INC | 0001047469-04-018252 ↗ |
| 2004-06-09 | S-1/A | S-1/A (amendment) | SENOMYX INC | 0001047469-04-019754 ↗ |
| 2004-06-17 | S-1/A | S-1/A (amendment) | SENOMYX INC | 0001047469-04-020835 ↗ |
| 2004-06-18 | S-1/A | S-1/A (amendment) | SENOMYX INC | 0001047469-04-020986 ↗ |
| 2004-06-22 | 424B4 | 424B4 (final prospectus) | SENOMYX INC | 0001047469-04-021233 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2004-06-18 | S-1/A | registration statement | $6.00–$7.00 | 6,000,000 | - | Nasdaq SNMX | 4 | primary document; range, price line, shares headline, proceeds computed, price outside the range dropped, cover names 4 | document ↗ | |
| 2004-06-22 | 424B4 | final prospectus | $6.00 | 6,000,000 | $36,000,000 | Nasdaq SNMX | 4 | primary document; price sentence, shares headline, proceeds table, cover names 4 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| ZOLLER MARK | Officer | CSO and SVP Research; CSO & SVP Research; EVP Disc & Dvlp and CSO; EVP Disc & Dvlp & Chf Sci Off.; EVP Disc & Dvlp & Chf Sci Offr; EVP Disc & Dvlpmt, Chf Sci Off; EVP Discovery & Dev. & CSO; EVP Discovery & Dev. & CSO*; EVP Discovery & Develop. & CSO | 23 | 2006–2009 | |
| POYHONEN JOHN | Director,Officer; Officer | Pres. and COO; Pres. & COO; President and COO; President & CEO; See General Remarks; See Remarks; SVP, CFO and Business Officer; SVP CFO & Business Officer; SVP, CFO, Business Officer; SVP Chf Fin & Bus Off; SVP Chf Fin & Bus. Off; SVP Chf Fin & Bus Officer; SVP Chf Fin. & Bus. Officer; SVP Chf Fin & Bus. Offr; SVP Chf Fin & Chf Bus Off.; VP Chf Fin. Off. & Bus Off. | 40 | 2006–2018 | |
| SNYDER KENT | Director; Director,Officer; Officer | CEO and Chairman of the Board; CEO & Chairman of the Board; President and CEO; President & CEO | 47 | 2006–2018 | |
| LESCHLY MARK | Director | 5 | 2006–2007 | ||
| BEELEY NIGEL R A | Officer | VP Discovery | 2 | 2006 | |
| LEONHARDT HARRY J | Officer | SVP Gen Counsel & Corp Scty; SVP Gen Counsel & Corp Sec; SVP Gen. Counsel & Corp Sec.; SVP, Gen Counsel & Corp Sec; SVP, Gen. Counsel & Corp. Sec.; SVP, Gen.Counsel & Corp. Sec.; SVP Gen Counsel & Corp Sectry; SVP Gen Counsel & Corp Secty; SVP Gen. Counsel & Corp Secty; SVP, Gen Counsel & Corp Secty; SVP, Gen Counsel & Corp. Secty | 21 | 2006–2007 | |
| SCHNELL DAVID | Director | 1 | 2006 | ||
| TWOMEY CHRISTOPHER J | Director | 18 | 2006–2018 | person page Fuzzy | |
| OBrien Dennis F | Director | 7 | 2006–2009 | person page Fuzzy | |
| Wicker Sharon | Officer | See Remarks; See Remarks*; Sr VP & Chf Comm Dvlpt Officer; Sr VP, Com Dvlp, Chf Strgy Off; Sr VP, Comm. Dvlp & CSO; Sr VP Commercialization & CSO* | 34 | 2006–2018 | |
| BLOCK STEPHEN A | Director | 19 | 2006–2018 | ||
| HERMAN MICHAEL E | Director | 19 | 2006–2017 | ||
| SHORT JAY M PHD | Director | 17 | 2006–2016 | ||
| BERGER DAVID B | Officer | Sr. V.P. Gen. Counsel & Sec.; VP, Gen. Counsel & Corp. Sec.; V.P. General Counsel & Sec. | 15 | 2008–2013 | |
| BILLINGSLEY ROGER D | Director | 13 | 2008–2015 | ||
| KARANEWSKY DONALD | Officer | See Remarks; Senior V.P. & CSO; Sr. VP and CSO; Sr. V.P., Discovery | 13 | 2009–2015 | |
| ROGERS ANTONY E | Officer | Senior VP and CFO; Senior V.P. & CFO; Sr VP & CFO; Sr. V.P. & CFO; V.P. and CFO; VP and CFO | 16 | 2009–2017 | |
| GRAY MARY ANN | Director | 12 | 2010–2018 | ||
| MASHAAL RICHARD R | TenPercentOwner | 4 | 2014–2018 | ||
| RIMA SENVEST MANAGEMENT, L.L.C. | TenPercentOwner | 4 | 2014–2018 | ||
| Lee Catherine Chai-zon | Officer | Sr. V.P. Gen. Counsel & Sec.; SVP, GC and Corp. Secretary; VP, GC and Corp. Secretary | 5 | 2015–2018 | |
| Stebbins Daniel Edward | Director | 6 | 2015–2018 | ||
| Humphrey David Carl | Officer | Vice President, Finance; V.P. & Chief Financial Officer | 3 | 2017–2018 | |
| Erdmann E Thomas III | Director | 4 | 2018 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| SEC filer | SENOMYX INC | SEC filers (EDGAR) | CIK (EXACT) | |
| Form 5500 plan sponsor | SENOMYX, INC. | EIN (EXACT) | ||
| Person page | Christopher J Twomey | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) | |
| Person page | Dennis F O'Brien | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Services-Commercial Physical & Biological Research, CA first:
- COMBICHEM INC CA
- AURORA BIOSCIENCES CORP CA
- SIGNAL PHARMACEUTICALS INC CA
- DELTAGEN INC CA
- MAXYGEN INC CA
- KOSAN BIOSCIENCES INC CA
- CytoCore, Inc. CA
- diaDexus, Inc. (pre-merger) CA
- DNA SCIENCES INC CA
- KINEMED INC CA
In other datasets, the same topic (Medical research) in CA:
- Nonprofit: 23ANDME RESEARCH INSTITUTE (Nonprofits (IRS Form 990))
Interests: Services-Commercial Physical & Biological Research · Medical research